February 7-8, 2018 NVAC Meeting

February 7, 2018 - February 8, 2018

Agenda

Day 1 – Wednesday, February 7th

Time	Agenda Item	Presenter(s)
9:00 – 9:10 a.m.	Welcome, Roll Call, and Rules of Engagement	Dr. Angela Shen, Designated Federal Officer
9:10 – 9:20 a.m.	Opening Remarks	Dr. Don Wright, Acting Assistant Secretary for Health
9:20 – 9:30 a.m.	NVPO Update	Dr. Melinda Wharton, Acting Director, NVPO
9:30 – 9:45 a.m.	NVAC Chair Update	Dr. Kimberly Thompson, NVAC Chair
9:45 a.m. – 12:30 p.m.	Update on Implementation of HPV Recommendations
9:45 – 10:00 a.m.	Overview: HPV Report Recommendations	Dr. Nathaniel Smith, NVAC Voting Member
10:00 – 10:15 a.m.	Surveillance Update and Overview of CDC Activities	Dr. Melinda Wharton, CDC
10:15 – 10:30 a.m.	NCI Cancer Control Research	Dr. Sarah Kobrin, NCI
10:30 – 10:45 a.m.	NCI’s Research Efforts on Reduced-dose HPV Vaccination	Dr. John Schiller, NCI (on behalf of Dr. Aimée Kreimer, NCI)
10:45 – 11:00 a.m.	HPV Case Study: Denver Health	Dr. Anna-Lisa Farmar, Denver Health
11:00 – 11:15 a.m.	Break
11:15 – 11:30 a.m.	HPV Vaccination Initiatives at the American Cancer Society	Dr. Debbie Saslow, ACS (presentation via phone)
11:30 a.m. – 12:00 p.m.	Round Robin: Partner Updates and Implementation Activities
		Dr. Anne Edwards, AAP Dr. Pamela G. Rockwell, AAFP Dr. Jennie Yoost, ACOG Dr. Cynthia Rand, APA Ms. Margaret Farrell, NCI, on behalf of CCCNP Ms. Gretchen Forsell, AHEC Dr. Amy Middleman, SAHM Dr. Ruth Lipman, ADA Dr. Frances Kim, AAPHD (presentation via phone)
12:00 – 12:30 p.m.	Discussion
12:30 – 1:45 p.m.	Lunch
1:45 – 2:30 p.m.	Vaccine Innovation: Updates
1:45 – 1:55 p.m.	Incentivizing the Development of Vaccines: Recommendations from the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria	Dr. Timothy Cooke, NVAC Voting Member and PACCARB Vaccine Working Group Member
1:55 – 2:10 p.m.	Zika Vaccine Development Update	Dr. Robert Johnson, ASPR-BARDA
2:10 – 2:30 p.m.	Discussion
2:30 – 3:15 p.m.	Vaccine Innovation: Next Generation Influenza Vaccine Development
2:30 – 2:40 p.m.	Next Generational Influenza Vaccine Development	Dr. Robert Johnson, ASPR-BARDA
2:40 – 2:50 p.m.	NIAID Universal Influenza Vaccine Portfolio	Dr. Teresa Hauguel, NIH
2:50 – 3:15 p.m.	Discussion
3:15 – 3:30 p.m.	Break
3:30 – 5:15 p.m.	Vaccine Innovation: Vaccine Adjuvants
3:30 – 3:45 p.m.	Overview of Progress and Landscape in Adjuvants	Dr. Karin Bok, NVPO
3:45 – 4:05 p.m.	The NIAID Vaccine Adjuvant Program: A Pipeline of Novel Compounds to Safely Enhance Vaccine Efficacy	Dr. Wolfgang Leitner, NIH
4:05 – 4:25 p.m.	Precision Vaccines: Using Adjuvants to Bring Precision Medicine to Vaccinology	Dr. Ofer Levy, Boston Children’s Hospital
4:25 – 4:45 p.m.	Vaccine Adjuvants	Dr. Leonard Friedland, NVAC Member/BIO
4:45 – 5:15 p.m.	Discussion
5:15 – 5:30 p.m.	Public Comment
5:30 p.m.	Day 1 Wrap Up and Adjourn	Dr. Kimberly Thompson, NVAC Chair

Day 2 – Thursday, February 8th

Time	Agenda Item	Presenter(s)
9:00 – 9:05 a.m.	Welcome and Wrap Up from Previous Day	Dr. Kimberly Thompson, NVAC Chair
9:05 – 10:15 a.m.	NVAC Liaison and Ex Officio Updates
9:05 – 9:15 a.m.	Agency Highlight: 2017-2018 Flu Season Update	Ms. Lynnette Brammer, CDC (presentation via phone)
9:15 – 9:45 a.m.	Ex Officio Member Updates	AHRQ, ASPR-BARDA, CDC, CMS, DoD, FDA, HRSA-BPHC, HRSA-DICP, IHS, NIH, USAID, USDA, VA
9:45 – 10:15 a.m.	Liaison Member Updates	ACCV, ACIP, AHIP, AIM, AIRA, APhA, ASTHO, NACCHO, PHAC, PAHO, VRBPAC
10:15 – 10:45 a.m.	National Adult and Influenza Immunization Summit and National Immunization Conference
10:15 – 10:30 a.m.	Working Group Updates, 2018 NAIIS, and NIC	Dr. Litjen Tan, IAC, on Behalf of NAIIS Co-Chairs (CDC, IAC, and NVPO)
10:30 – 10:45 a.m.	Discussion
10:45 – 11:00 a.m.	Break
11:00 a.m. – 12:15 p.m.	Disparities in Adult Immunizations
11:00 – 11:15 a.m.	Disparities in Adult Immunization – 2016 NHIS	Dr. Ram Koppaka, CDC
11:15 – 11:30 a.m.	Understanding Dynamics Underlying Racial Disparities in Influenza Vaccination	Dr. Sandra Crouse Quinn, University of Maryland
11:30 – 11:45 a.m.	CMS Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) Improving Medicare Beneficiary Immunizations Among Disparate Populations	Dr. Shiree Southerland, CMS
11:45 – 12:15 p.m.	Discussion
12:15 – 12:30 p.m.	Public Comment
12:30 p.m.	Closing Remarks and Adjourn	Dr. Kimberly Thompson, NVAC Chair

Abbreviations

AAP — American Academy of Pediatrics

AAFP — American Academy of Family Physicians

ACCV — Advisory Commission on Childhood Vaccines

ACIP — Advisory Committee on Immunization Practices

ACOG — American College of Obstetricians and Gynecologists

ADA — American Dental Association

AHEC — Area Health Education Center

AHIP — America’s Health Insurance Plans

AHRQ — Agency for Healthcare Research and Quality

AIM — Association of Immunization Managers

AIRA — American Immunization Registry Association

APA — American Pediatric Association

APhA— American Pharmacists Association

ASPR — Assistant Secretary for Preparedness and Response

ASTHO — Association of State and Territorial Health Officials

BARDA — Biomedical Advanced Research and Development Authority

CCCNP — Comprehensive Cancer Control National Partnership

CDC — Centers for Disease Control and Prevention

CMS — Centers for Medicare and Medicaid Services

DoD — Department of Defense

FDA — Food and Drug Administration

HRSA-BPHC — Health Resources and Services Administration - Bureau of Primary Healthcare

HRSA-DICP — Health Resources and Services Administration - Division of Injury Compensation

IHS — Indian Health Service

NACCHO — National Association of County and City Health Officials

NCI — National Cancer Institute

NIAID — National Institute of Allergy and Infectious Diseases

NIH — National Institutes of Health

PACCARB — Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

PAHO — Pan American Health Organization

PHAC — Public Health Agency of Canada

SAHM — Society for Adolescent Health and Medicine

USAID — U.S. Agency for International Development

USDA — U.S. Department of Agriculture

VA — Department of Veterans Affairs

VRBPAC — Vaccines and Related Biological Products Advisory Committee